I
n the United States, lung cancer is the most frequently diagnosed invasive cancer. Because it is difficult to treat, it is also the leading cause of cancer deaths, accounting for approximately 158,000 deaths each year in the United States. 1 Although this cancer occurs throughout the United States population, incidence rates vary considerably between racial and ethnic populations, particularly because of the variations in tobacco use across the United States. Cigarette smoking is the most important cause of lung cancer, accounting for 90% of lung cancer deaths in males and 75%-80% of lung cancer deaths in females in the United States. [2] [3] [4] Exposure to other risk factors for lung cancer, such as asbestos, naturally occurring radon gas in homes, and an occupational history of uranium mining, also are contributors. 1, [5] [6] [7] [8] [9] [10] [11] [12] Several studies have demonstrated that AI/AN cancer incidence historically has been underreported with the result that the burden of cancer in this population has been described inaccurately. [13] [14] [15] [16] This underreporting has 2 sources: First, AI/AN cancer incidence rates reported in the Surveillance, Epidemiology, and End Results (SEER) data were dominated by the large AI population ascertained by the New Mexico Tumor Registry (NMTR), which is one of the original SEER cancer registries, and often were cited as representative of all AI/AN populations in the United States. However, lung cancer incidence rates in the Southwestern AI population, as reflected in the NMTR data, are much lower than in other regions. 17 A second source of the underreporting is that the race of AI/ ANs often is misclassified in medical records, vital statistics, cancer registries, and other databases. Linking state cancer registry data with Indian Health Service (IHS) patient registration information can correct some underreporting because of the misclassification of race. In previous linkage studies, AI/AN mortality and incidence rates in some locations have doubled subsequent to such linkages. 18, 19 The objective of this study was to reduce the misclassification of AI/AN race through linkages with analyses restricted to the IHS Contract Health Services Delivery Area (CHSDA) counties, where a larger percent of the population is AI/AN and misclassification of AI/AN race is believed to be lower than in other counties. 20 The cancer data used in this study are from population-based cancer registries across the United States and thereby provide an opportunity to present a more complete picture of lung cancer incidence in regional AI/AN populations.
MATERIALS AND METHODS

Case Identification
The cancer incidence data for this study were obtained from state and regional cancer registries throughout the United States for cases diagnosed during 1999 through 2004. All of these registries participate in either the Centers for Disease Control and Prevention's (CDC) National Program of Cancer Registries (NPCR) or the National Cancer Institute's (NCI) SEER Program, 21 or both. Data were included from those registries that agreed to participate and met the United States Cancer Statistics standards for high-quality data. 21 Only 4 states were excluded from the analysis: Kansas, Maryland, South Carolina, and Vermont. Primary cancer site and histology data were coded according to the International Classification of Diseases for Oncology (ICD-O) edition in that was use at the time of diagnosis and are converted to the third edition. 22 Invasive lung cancer cases were identified with the ICD-O version 3 codes C340 through C349. 22 Histologies that involved hematopoietic diseases, mesothelioma, and Kaposi sarcoma were excluded (M9590-9989, 9050-9055, and 9140 25 To obtain the most accurate race information, states worked with the IHS to link cancer registry databases with IHS patient registration data. This linkage effectively identified those individuals who may not have been classified as AI/AN in the state cancer registries but were known to be members of federally recognized tribes and enrolled in the IHS healthcare system. If an individual was not identified as AI/AN in the cancer registry but was identified as AI/AN in the IHS database, then the individual was classified as AI/AN for this analysis. For more details about the linkage methodology, see the report by Espey et al in this supplement to Cancer. 26 Hispanic origin was identified for all individuals in the registry databases using the North American Association of Central Cancer Registry Hispanic Identification Algo-rithm. 27 Individuals who were included in the AI/AN race category were included regardless of Hispanic origin. For all analyses, AI/ANs were compared with NHWs.
Population Estimates, Regional Definitions, and Geographic Coverage
County level annual population estimates for the years 1999 through 2004 were modified in 2 ways to be used in the denominators of the rate calculations. First, since 2000, the population estimates from the US Bureau of the Census have included data from individuals who identify themselves as belonging to more than 1 racial group. The CDC National Center for Health Statistics collaborated with the Bureau of the Census to develop methods for converting the multiple race data collected into single race categories. 28 Second, the NCI provided additional refinements to race and county codes for use in the SEER*Stat software program. 29, 30 To assess regional variation in incidence, the states were grouped into 6 previously developed IHS regions (Fig. 1) . 26 The 'allcounties' incidence rates, for which no geographic restrictions apply, included data from registries in 46 states and the District of Columbia. For most tabulations, however, the analyses were restricted to 'Contract Health Service Delivery Area' (CHSDA) counties, which, in general, contain federally recognized tribal lands or are adjacent to tribal lands (Fig. 1) . For incidence rates restricted to CHSDA counties, data from 33 registries were included. Restricting the analysis to CHSDA counties was another method used to minimize racial misclassification. 26 Approximately 56% of the United States AI/AN population resides in CHSDA counties. This proportion varies by IHS region (Alaska, 100%; East, 13.1%; Northern Plains, 59%; Southern Plains, 64.1%; Pacific Coast, 55.6%; Southwest, 87.5%).
Statistical Analysis
Age-adjusted lung cancer incidence rates, expressed as the number of cases per 100,000 population and age-adjusted by 19 age groups to the 2000 United States standard population, were calculated for AI/ AN and NHW populations using SEER*Stat software version 6.3.6. 30 Percent distributions for stage and histology also were age-adjusted to the same standard population. For all analyses, exact counts were suppressed when the category of interest contained <6 cases.
By using the age-adjusted incidence rates, standardized rate ratios (RRs) were calculated for AI/AN populations using NHW rates for comparison. Confidence intervals (CIs) for age-adjusted rates and standardized RRs were calculated based on methods described by Tiwari et al 31 
RESULTS
Lung cancer incidence rates in CHSDA counties varied nearly 7-fold for AI/ANs across IHS regions in the United States (Table 1) . Among AI/ANs, rates were highest in the Northern Plains (104.3), Alaska (93.2), and the Southern Plains (87.1) and lowest in the Southwest (14.9). This same pattern was observed in the analysis of all counties combined, although the rates were lower and the variation was nearly 5-fold. Lung cancer incidence rates for NHWs did not exhibit the same magnitude of variation or the same pattern of regional variation; in the CHSDA counties, NHW rates were highest in the Southern Plains (82.2) and the East (74.2). All subsequent presentations of data refer to CHSDA county data unless noted otherwise.
Among the populations living in CHSDA counties, AI/ANs had significantly higher rates (P < .05) of lung cancer than NHWs for both males and females in the Northern Plains and Alaska and for females in the Southern Plains (Table 1 ). In the Southern Plains, AI/AN males had lung cancer incidence rates that were approximately the same as those for NHWs, although that rate was significantly higher than the national NHW rate. In contrast, incidence rates for AI/ANs in the Pacific Coast, East, and Southwest regions all were significantly lower than the rates for NHWs in the same regions for both males and females (Table 1 , Fig. 2 ). 32 From 1999 through 2004, male NHW lung cancer incidence rates decreased significantly for all regions combined, whereas male AI/AN rates remained approximately level (Table 2) . Over the same period, rates among AI/AN females and NHW females did not change.
The highest rates among AI/ANs for each age group were in the Northern Plains, Alaska, and the Southern Plains (Table 3 ). Similar regional patterns were not observed for NHWs, and their highest rates were observed among those living in the Southern Plains and the East. Like for many other forms of cancer, rates increased with age, and the highest rates occurred in the oldest age group (aged 65 years). Among individuals aged 50 years, lung cancer incidence rates were significantly higher among AI/ANs than among NHWs in the Northern Plains and Alaska. Also, among individuals aged 50 years, the rates were significantly lower among AI/ ANs than among NHWs in the Southwest, East, and Pacific Coast regions. AI/ANs were diagnosed with lung cancer at younger ages than NHWs. Among AI/ ANs, 58.5% of cases were aged 65 years at diagnosis compared with 70.2% of cases among NHWs. Table 4 displays an analysis of the lung cancer incidence by disease stage at diagnosis among AI/ ANs and NHWs for CHSDA counties in the 6 IHS regions. For both populations across all regions, approximately 44% of cases were diagnosed at a distant stage. In the Southwest, AI/ANs had the highest percentage of distant-stage disease (53.3%) and the lowest percentage of local-stage disease (11.3%). Although AI/ANs in the Southern Plains had among the higher lung cancer incidence rates, AI/ANs in the same region had the lowest percentage of cases diagnosed with distant-stage disease (40.5%). For all regions combined, AI/AN females were more likely than AI/AN males to have their lung cancer diagnosed at a local stage and to have less distant-stage disease (data not shown). Among NHWs, the highest proportion of distant-stage disease was observed in the Pacific Coast and Alaska regions; the percentage stage distributions did not differ appreciably by sex (data not shown).
A comparison of the percentage distribution of histologic type among microscopically confirmed lung and bronchus cancer in cases between AI/ANs and NHWs in CHSDA counties is presented in Table  5 . For all regions combined, AI/ANs had relatively less adenocarcinoma (29.2%) and slightly more squamous cell histology (24.0%) than NHWs (37.1% and 20.4%, respectively), except in the Southern Plains and Southwest, where the histology distributions for the 2 populations were similar.
DISCUSSION
This is the most comprehensive study of the incidence of lung cancer among the AI/AN populations in the United States to date. Combining NPCR and SEER data for broad population coverage and using linkages to improve on the misclassification of race among AI/ANs provided the opportunity to describe both regional and national estimates of lung cancer incidence for AI/ANs. Our findings confirmed the dramatic regional differences in lung cancer rates that have been reported in studies using death certificates. 16 Lung cancer incidence rates in AI/ANs var- ied 7-fold across IHS regions (in CHSDA counties), with the highest rates observed in the Northern and Southern Plains and Alaska and the lowest rates observed in the Southwest. AI/AN males and females were diagnosed with lung cancer at a younger age than NHWs, but the distribution of disease stage did not differ between the 2 populations. Adenocarcinoma was less common and squamous cell histology was slightly more common among AI/ANs than among NHWs. Cigarette smoking and exposure to environmental tobacco have been linked directly to lung cancer and many other diseases, including heart disease, stroke, and multiple cancers, 2,3,33 that translate into multibillion dollar medical and lost productivity costs in the United States. 34 AI/ANs have the highest prevalence of daily cigarette use of any population in the United States. 35 The prevalence of tobacco use varies greatly among AI/ANs by region. 36 Thus, regional lung cancer rates also can be expected to vary; and, similar to the current study, such variations were observed in earlier incidence and mortality studies. [13] [14] [15] [16] 37 Tobacco use survey information must be interpreted with caution, because many American Indians use tobacco for traditional or ceremonial purposes and may or may not also be habitual smokers. 38, 39 Tobacco has been a key element in the ceremonial practices of many American Indian people from pre- 36, [38] [39] [40] According to aggregate data from the 2000 through 2006 BRFSS, AI/AN respondents were more likely to be currently smoking cigarettes (31.1%) than the NHW population (22.8%). 36 Current cigarette smoking was highest in the Northern Plains (40.2%) and Alaska (40%) and was lowest in the Southwest (21.1%). 36 For all racial and ethnic groups, data on current cigarette smoking from the 2006 National Health Interview Survey show the highest rate among AI/ANs (26.9%), followed by NHWs (22.6%), Native Hawaiian/Pacific Islanders (22.5%), African Americans (21.8%), Hispanics (14.5%), and Asians (10.7%). 35 Although it is estimated that tobacco is a causal factor in nearly 90% of lung cancers, other occupational and environmental exposures also are known lung carcinogens. These include asbestos, radon, arsenic, and uranium mining. 1 According to a 1999 Institute of Medicine report, an estimated 21,800 new diagnoses of lung cancer are related to radon (14%) each year in the United States, which makes radon the second leading cause of lung cancer deaths after cigarette smoking. 41 Other studies have suggested a synergistic relation between radon exposure and cigarette smoking that may increase the risk of lung cancer to 6 to 10 times higher than among nonsmokers. 11, 12, 42 Radon gas occurs naturally in small amounts in soils and rocks throughout the United States. Radon can become trapped in homes and other structures, creating the potential for elevated exposure. 43 The Environmental Protection Agency (EPA) has established 4 pico Curies per liter (pCi/L) as the threshold above which action should be taken to alter a structure to reduce radon exposure. 44 EPA maps of radon zones indicate that homes in the part of the country with a high proportion of AI/ANs contain high (4 pCi/L) or moderate (2 pCi/L) levels of radon, which may contribute to some cases of lung cancer among AI/ANs. 45 Another form of exposure to radon is in the process of uranium mining. This occupational exposure has long been documented as a strong causal factor in the development of lung cancer. In the Southwest, many AI/AN males worked in uranium mines in the 1950s and 1960s; it has been demonstrated that this is an important cause of lung cancer in a population that historically has had a very low prevalence of smoking. 5, 6 The Southwest region has had the lowest lung cancer incidence rates, despite the extensive exposure to uranium mining that occurred in that region.
Other known risk factors for lung cancer may include tuberculosis and chronic obstructive pulmonary disease. 46 Exposure to arsenic, chromium, nickel, aromatic hydrocarbons, and ethers, most commonly in an occupational setting, also may increase the risk of lung cancer. 47 The IHS patient registration database contains records of individuals who are members of federally recognized tribes, and linking these data with SEER and NPCR registries corrected some of the misclassification of race for AI/ANs. 26 Restricting the sample to the CHSDA counties also contributed to improved rate estimates, because AI/ANs in those counties are more likely to be registered for care with the IHS, and less misclassification has been noted in these counties. 20 Because misclassification of AI/AN race is so common in both state and national databases, 18, [48] [49] [50] [51] these processes contributed to improved descriptions of the lung cancer burden for AI/ANs. Despite these improvements, there are some limitations to the data. Because most analyses were restricted to CHSDA counties, in which only 56% of AI/ANs live and which tend to be located in more rural areas and Western states (Fig. 1) , the results may not be generalizable to all AI/ANs (or NHWs) in the United States. In addition, the percentage of AI/ANs residing in CHSDA counties varied greatly among the 6 IHS regions ( Table 1 ). The percentage was particularly low in the East region (13.1%), which may help to explain the puzzling occurrence in this region of relatively low lung cancer incidence rates and high prevalence estimates of cigarette smoking. 36 Another limitation is that IHS records capture only enrolled members of recognized tribes who seek healthcare from the IHS and, thus, do not include others who may self-identify in the United States Census as AI/AN, notably urban AI/ANs and those who are from tribes not recognized by the federal government. Misclassification is likely to be greatest in the Pacific Coast and East regions, where the IHS has a relatively small presence and only serves a small percentage of AI/ANs.
To our knowledge, this is the most complete accounting of lung cancer occurrence among AI/AN to date and demonstrates the substantial differences in the incidence of this deadly cancer among the var-ious AI/AN populations. Until the 1990s, most AI/ ANs were not included in areas that were covered by high-quality, population-based cancer registries. Currently, the NPCR and SEER annually produce the United States Cancer Statistics, covering 98% of United States population. 21 In fact, national rates of lung cancer incidence for all races combined reportedly were higher than had been noted before United States Cancer Statistics availability. 52 Although the methods used for this analysis improved the completeness of reporting cancers among AI/AN by correcting for some of the misclassification of race, the linkage protocols need to be continued. Furthermore, additional linkages with tribal rosters that were not included in the current efforts are needed to further improve the misclassification of race in AI/AN populations.
In conclusion, lung cancer is a significant problem for a large portion of AI/AN populations, notably those who live in the Northern Plains states and Alaska, where dramatic disparities in lung cancer incidence rates exist between AI/AN and NHW populations. AI/ANs in these regions have high estimates of smoking prevalence compared with NHWs 36 as well as high lung cancer incidence rates. The 7-fold difference between the lowest and highest lung cancer rates (Southwest vs Northern Plains) likely reflects in large part the strong association between cigarette smoking and the development of lung cancer. Indeed, BRFSS and local survey data indicate that AI/ANs in Alaska and the Plains use tobacco at rates higher than any other racial or ethnic population in the United States. 39 Our study underscores the need for aggressive tobacco control programs within AI/AN populations and communities.
